International Society of Nephrology: Industry Supported Content

ISN Webinar: Challenges in implementing PD preferred/first policies across the globe

Contains 1 Component(s) Recorded On: 10/17/2025
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Free trial - Free!
  
  Continue
- More Information
ISN Webinar: Understanding C3G: Pathophysiology, Diagnosis, and Therapeutic Approaches

Contains 1 Component(s) Recorded On: 09/29/2025
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Free trial - Free!
  
  Continue
- More Information
ISN Webinar: Optimizing RAASi Therapy in Clinical Practice: A Case-Based Discussion

Contains 1 Component(s) Recorded On: 09/17/2025
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Free trial - Free!
  
  Continue
- More Information
ISN GREEN-K Webinar: Advances in green technologies

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
ISN GREEN-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
ISN Webinar: Current evidence and the future role of non-steroidal mineralocorticoid receptor antagonists in kidney and cardiovascular disease

Contains 1 Component(s) Recorded On: 04/30/2025
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Free trial - Free!
  
  Continue
- More Information
ISN GREEN-K Webinar: Green Experiences and Challenges from LMIC

Contains 1 Component(s) Recorded On: 04/22/2025
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
Industry Webinar: A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan

Contains 1 Component(s) Recorded On: 03/12/2025
- Register
  Non-member - Free!
  
  Member - Free!
  
  Subscriber - Free!
  
  Free trial - Free!
  
  Continue
- More Information
ISN Webinar: Understanding the cardiovascular effects of GLP-1 Receptor Agonists and implications in patients with CKD and cardiovascular disease

Contains 1 Component(s) Recorded On: 03/07/2025
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information
Long-term Results from an Open-label Extension Study of Atacicept for the Treatment of IgA Nephropathy

Contains 1 Component(s)
- Register
  Member - Free!
  
  Subscriber - Free!
  
  Continue
- More Information

Industry Supported Content

ISN Webinar: Challenges in implementing PD preferred/first policies across the globe

ISN Webinar: Understanding C3G: Pathophysiology, Diagnosis, and Therapeutic Approaches

ISN Webinar: Optimizing RAASi Therapy in Clinical Practice: A Case-Based Discussion

ISN GREEN-K Webinar: Advances in green technologies

ISN GREEN-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right

ISN Webinar: Current evidence and the future role of non-steroidal mineralocorticoid receptor antagonists in kidney and cardiovascular disease

ISN GREEN-K Webinar: Green Experiences and Challenges from LMIC

Industry Webinar: A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan

ISN Webinar: Understanding the cardiovascular effects of GLP-1 Receptor Agonists and implications in patients with CKD and cardiovascular disease

Long-term Results from an Open-label Extension Study of Atacicept for the Treatment of IgA Nephropathy

Global Operations Center

Americas Operations Center

Industry Supported Content

ISN Webinar: Challenges in implementing PD preferred/first policies across the globe

ISN Webinar: Understanding C3G: Pathophysiology, Diagnosis, and Therapeutic Approaches

ISN Webinar: Optimizing RAASi Therapy in Clinical Practice: A Case-Based Discussion

ISN GREEN-K Webinar: Advances in green technologies

ISN GREEN-K Webinar: Ethical challenges for Green Nephrology: getting the priorities right

ISN Webinar: Current evidence and the future role of non-steroidal mineralocorticoid receptor antagonists in kidney and cardiovascular disease

ISN GREEN-K Webinar: Green Experiences and Challenges from LMIC

Industry Webinar: A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan

ISN Webinar: Understanding the cardiovascular effects of GLP-1 Receptor Agonists and implications in patients with CKD and cardiovascular disease

Long-term Results from an Open-label Extension Study of Atacicept for the Treatment of IgA Nephropathy

Global Operations Center

Americas Operations Center

Follow Us